Aflac Incorporated

(New York Stock Exchange)
Back to all articles
Neutral +5

Aflac (NYSE:AFL) Major Shareholder Post Holdings Co. Ltd. Japan Sells ...

AI-generated analysis

πŸ“‰ Major shareholder Post Holdings Co. Ltd. Japan sold 13,300 shares on September 10th for $1.52 million under a pre-arranged Rule 10b5-1 trading plan.

πŸ’° Aflac reported Q2 earnings of $1.75 per share, missing analyst estimates by $0.01 despite revenue beating expectations at $4.22 billion.

πŸ“Š The company achieved a net margin of 26.91% and a return on equity of 13.27%, with revenue declining 1.0% year-over-year.

πŸ’΅ Aflac paid a quarterly dividend of $0.61 per share, yielding 2.1% annually with a payout ratio of 26.15%.

πŸ“ˆ Morgan Stanley increased its price objective to $125.00 and maintained an 'equal weight' rating on the stock.

πŸ“‰ Barclays reissued an 'underweight' rating with a target price of $99.00, while JPMorgan Chase lowered its target to $116.00.

🏦 Institutional investors own 67.44% of Aflac's stock, including new positions from Whipplewood Advisors and Groupe la Francaise.

πŸ“‰ The stock trades with a PE ratio of 12.54 and a beta of 0.59, currently positioned between its 50-day moving average of $121.01 and one-year low of $105.43.

Bullish Signals
  • Aflac reported revenue of $4.22 billion for the quarter, exceeding analyst estimates of $4.11 billion.
  • The company achieved a strong net margin of 26.91% and a return on equity of 13.27% during the reporting period.
  • Morgan Stanley increased its price objective to $125.00, signaling confidence in the stock's valuation potential.
Risk Factors
  • Aflac reported earnings per share of $1.75, missing analyst consensus estimates by $0.01.
  • Revenue declined 1.0% on a year-over-year basis during the second quarter.
  • Barclays reissued an 'underweight' rating with a target price of $99.00, below current trading levels.
Full Analysis
Aflac Incorporated (NYSE:AFL) saw a minor reduction in its major shareholder position as Post Holdings Co. Ltd. Japan sold 13,300 shares on September 10th for approximately $1.52 million under a pre-arranged Rule 10b5-1 trading plan. Following the transaction, the insider retained 50,612,190 shares, representing a negligible 0.03% decrease in their overall stake. The company continues to operate as a significant provider of supplemental health and life insurance products in both the United States and Japan. Financially, Aflac reported Q2 earnings of $1.75 per share, slightly missing analyst consensus estimates of $1.76, though revenue of $4.22 billion exceeded expectations at $4.11 billion. The company achieved a net margin of 26.91% and a return on equity of 13.27%, with revenue declining 1.0% year-over-year. The firm recently paid a quarterly dividend of $0.61 per share, resulting in an annualized yield of 2.1% and a payout ratio of 26.15%. Analyst sentiment remains mixed regarding the stock's valuation and outlook. While Morgan Stanley raised its price objective to $125.00 with an 'equal weight' rating, other major institutions like Barclays, Wells Fargo, and JPMorgan Chase maintained neutral or underweight ratings with target prices hovering near current market levels. The consensus rating from MarketBeat is 'Hold' with a target price of $116.62, reflecting the stock's trading range between its 50-day moving average of $121.01 and one-year low of $105.43.